Drug
Epothilone B clinical trials
Also written Patupilone and EPO906.
- studies test it
- 28
- open now
- 0
- in phase 3
- 1
- first study started
- 2001
How studies write it
Studies that test it under each name
Development codes
Other names
Combined with it in one product
Studies by the year they started
28 studies that test it; most in 2006 (8)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 6 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 8 |
| 2007 | 6 |
| 2008 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 15
- Phase 2
- 15
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 22 · Other 6
Novartis Pharmaceuticals (22) · University of Southern California (1) · Sidney Kimmel Cancer Center at Thomas Jefferson University (1) · David Peereboom, MD (1) · University of Medicine and Dentistry of New Jersey (1) · University of Zurich (1) · British Columbia Cancer Agency (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses epothilone B is read from its arms, and is right about nine times in ten.
Testing it · 28
- Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal CancerCompletedPhase 1/2University of Southern CaliforniaNCT00159484Written as EPO906
- EPO906 Plus Radiation Therapy for the Treatment of Cancer PatientsCompletedPhase 1Sidney Kimmel Cancer Center at Thomas Jefferson UniversityNCT00328458Written as EPO906 (epothilone B)
- Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung CancerCompletedPhase 2Novartis PharmaceuticalsNCT00219297Written as Patupilone
- Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal CancerCompletedPhase 3Novartis PharmaceuticalsNCT00262990Written as EPO906 (Patupilone)
- Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate CancerCompletedPhase 2Novartis PharmaceuticalsNCT00411528Written as Patupilone
- Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid TumorsCompletedPhase 1Novartis PharmaceuticalsNCT00426582Written as Patupilone
- A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionCompletedPhase 1Novartis PharmaceuticalsNCT00420524Written as Patupilone/EPO906
- Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies.CompletedPhase 1Novartis PharmaceuticalsNCT00426140Written as Patupilone
- Dose-Escalation Study in Advanced Colon Cancer PatientsCompletedPhase 1Novartis PharmaceuticalsNCT00969046Written as EPO906 (patupilone)
- Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced MalignanciesCompletedPhase 1Novartis PharmaceuticalsNCT00420615Written as Patupilone and Omeprazole
- EPO906 in Carcinoid and Other Neuroendocrine TumorsCompletedPhase 2Novartis PharmaceuticalsNCT00050349Written as EPO906 epothilone B
- EPO906 Therapy in Patients With Prostate CancerCompletedPhase 2Novartis PharmaceuticalsNCT00035113Written as epothilone b
- EPO906 Therapy in Patients With Advanced Breast CancerCompletedPhase 2Novartis PharmaceuticalsNCT00035126Written as epothilone b
- Patupilone Activity in Advanced/Metastatic Hepatocellular CarcinomaCompletedPhase 2Novartis PharmaceuticalsNCT00273312Written as Patupilone
- Epothilone B in Treating Patients With CNS Metastases From Breast CancerCompletedPhase 2David Peereboom, MDNCT00450866Written as epothilone B
- Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung CancerCompletedPhase 1/2Novartis PharmaceuticalsNCT00171834Written as Patupilone
- EPO906 Therapy in Patients With Advanced Colorectal CancerCompletedPhase 2Novartis PharmaceuticalsNCT00035087Written as epothilone b
- Phase I Study of Patupilone and RAD001CompletedPhase 1University of Medicine and Dentistry of New JerseyNCT00496600Written as Patupilone
- EPO906 Therapy in Patients With Advanced MelanomaCompletedPhase 2Novartis PharmaceuticalsNCT00035165Written as epothilone b
- Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension)WithdrawnPhase 1Novartis PharmaceuticalsNCT00442741Written as Patupilone
Codes
What other systems call epothilone B · ClinicalTrials.gg INT003847
- MeSH (NLM) C093788epothilone BConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) UEC0H0URSEPATUPILONEConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C093788 | epothilone B | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | UEC0H0URSE | PATUPILONE | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.